REGISTERED NUMBER: 13046592 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2025

FOR

PARNELL MEDICAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

M R Parnell

REGISTERED OFFICE:

The Stables

23b Lenten Street

Alton

Hampshire

GU34 1HG

REGISTERED NUMBER:

13046592 (England and Wales)

ACCOUNTANTS:

LFM

Chartered Certified Accountants

The Stables

23b Lenten Street

Alton

Hampshire

GU34 1HG

FIXED ASSETS

Tangible assets

4

2,316

558

Investments

5

67,575

-

69,891

558

CURRENT ASSETS

Debtors

6

159,055

112,598

Cash at bank

121,178

123,759

280,233

236,357

CREDITORS

Amounts falling due within one year

7

38,115

31,397

NET CURRENT ASSETS

242,118

204,960

TOTAL ASSETS LESS CURRENT LIABILITIES

312,009

205,518

PROVISIONS FOR LIABILITIES

2,466

140

NET ASSETS

309,543

205,378

CAPITAL AND RESERVES

Called up share capital

100

100

Fair value reserve

8

5,661

-

Retained earnings

303,782

205,278

SHAREHOLDERS' FUNDS

309,543

205,378

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 August 2026 and were signed by:

M R Parnell - Director

1.	STATUTORY INFORMATION

Parnell Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 December 2024

2,863

Additions

2,000

Disposals

(700

)

At 30 November 2025

4,163

DEPRECIATION

At 1 December 2024

2,305

Charge for year

242

Eliminated on disposal

(700

)

At 30 November 2025

1,847

NET BOOK VALUE

At 30 November 2025

2,316

At 30 November 2024

558

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST OR VALUATION

Additions

60,027

Revaluations

7,548

At 30 November 2025

67,575

NET BOOK VALUE

At 30 November 2025

67,575

Cost or valuation at 30 November 2025 is represented by:

Other

investments

£

Valuation in 2025

7,548

Cost

60,027

67,575

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

4,532

2,410

Amounts owed by group undertakings

153,751

109,751

Other debtors

772

437

159,055

112,598

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

274

274

Taxation and social security

31,178

28,085

Other creditors

6,663

3,038

38,115

31,397

8.

RESERVES

Fair

value

reserve

£

Transfer to FV reserve

5,661

At 30 November 2025

5,661

9.	ULTIMATE CONTROLLING PARTY

The controlling party is M R Parnell.